Evaluation of exposure‐response‐safety relationship of model‐informed low‐dose 500 mg abiraterone acetate in prostate cancer patients
Saved in:
| Main Authors: | Edmund Chiong, Ziteng Wang, Eleanor Jing Yi Cheong, Yi Chen Yao, Sin Mun Tham, Revathi Periaswami, Poh Choo Toh, Ziting Wang, Qing Hui Wu, Woon Chau Tsang, Arshvin Kesavan, Alvin Seng Cheong Wong, Patrick Thomas Wong, Felicia Lim, Shuaibing Liu, Eric Chun Yong Chan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | Cancer Communications |
| Online Access: | https://doi.org/10.1002/cac2.70035 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Revolutionizing immunization: a comprehensive review of mRNA vaccine technology and applications
by: Kai Yuan Leong, et al.
Published: (2025-03-01) -
A randomized, open-label, multi-center, active-controlled phase II study comparing abiraterone acetate tablets (II), an improved formulation, versus originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer
by: Xiaolin Lu, et al.
Published: (2025-05-01) -
Design of a 500w Inverter.
by: Kyomuhendo Medius
Published: (2023) -
A Super‐Enhancer‐Driven Transcriptional Regulatory Circuit Underlying Abiraterone Resistance in Castration‐Resistant Prostate Cancer
by: Liling Jiang, et al.
Published: (2025-08-01) -
500 Tips for Quality Enhancement in Universities and Colleges /
by: Sally Brown
Published: (1997)